BENSOUSSAN TORRES ROBERT 4

Accession 0001753926-25-000052

CIK 0000822663other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:07 PM ET

Size

36.7 KB

Accession

0001753926-25-000052

Insider Transaction Report

Form 4

Period: 2025-01-03

INTERPARFUMS INCIPAR

BENSOUSSAN TORRES ROBERT

Director

Transactions

Exercise/Conversion
Option-right to buy
2025-01-03−375→ 0 total
Exercise: $69.11From: 2021-02-01Exp: 2025-01-31→ Common Stock (375 underlying)
Exercise/Conversion
Option-right to buy
2025-01-03−375→ 0 total
Exercise: $69.11From: 2024-02-01Exp: 2025-01-31→ Common Stock (375 underlying)
Exercise/Conversion
Common Stock
2025-01-03$69.11/sh+1,500$103,665→ 11,000 total
Exercise/Conversion
Option-right to buy
2025-01-03−375→ 0 total
Exercise: $69.11From: 2022-02-01Exp: 2025-01-31→ Common Stock (375 underlying)
Exercise/Conversion
Option-right to buy
2025-01-03−375→ 0 total
Exercise: $69.11From: 2023-02-01Exp: 2025-01-31→ Common Stock (375 underlying)

Holdings

Common Stock
9,500
Option-right to buy
Exercise: $62.18From: 2022-02-01Exp: 2026-01-31→ Common Stock (375 underlying)
375
Option-right to buy
Exercise: $97.84From: 2024-12-31Exp: 2028-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $97.84From: 2027-12-31Exp: 2028-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $62.18From: 2023-02-01Exp: 2026-01-31→ Common Stock (375 underlying)
375
Option-right to buy
Exercise: $62.18From: 2025-02-01Exp: 2026-01-31→ Common Stock (375 underlying)
375
Option-right to buy
Exercise: $97.84From: 2026-12-31Exp: 2028-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $147.71From: 2025-12-29Exp: 2029-12-28→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $147.71From: 2026-12-29Exp: 2029-12-28→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $147.71From: 2028-12-29Exp: 2029-12-28→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $130.60From: 2027-12-31Exp: 2030-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $130.60From: 2029-12-31Exp: 2030-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $62.18From: 2024-02-01Exp: 2026-01-31→ Common Stock (375 underlying)
375
Option-right to buy
Exercise: $97.84From: 2023-12-31Exp: 2028-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $97.84From: 2025-12-31Exp: 2028-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $147.71From: 2024-12-29Exp: 2029-12-28→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $147.71From: 2027-12-29Exp: 2029-12-28→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $130.60From: 2025-12-31Exp: 2030-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $130.60From: 2026-12-31Exp: 2030-12-30→ Common Stock (300 underlying)
300
Option-right to buy
Exercise: $130.60From: 2028-12-31Exp: 2030-12-30→ Common Stock (300 underlying)
300

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTERPARFUMS INC

CIK 0000822663

→

Entity typeother

Related Parties

filerCIK 0001211775

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 4:07 PM ET
Size: 36.7 KB

View on SEC.gov